What we are studying
The purpose of this study is to find out whether treatment with the drugs paclitaxel and carboplatin work better to control your cancer than treatment with the drugs bleomycin, etoposide and cisplatin, which is the standard treatment for your type of cancer. Another purpose of this study is to find out what side effects are caused by treatment with these drug combinations. Another purpose of this study is to examine whether inhibin levels (a blood test) might be a good way to know how someone is responding to treatment. In this study you will get paclitaxel and carboplatin (considered the experimental therapy) or bleomycin, etoposide and cisplatin (considered the standard therapy).
Additionally, more will be learned about this specific type of rare ovarian cancer by studying certain markers and substances.